1. Home
  2. EA vs ZTS Comparison

EA vs ZTS Comparison

Compare EA & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electronic Arts Inc.

EA

Electronic Arts Inc.

HOLD

Current Price

$199.66

Market Cap

50.4B

Sector

Technology

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$127.34

Market Cap

54.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EA
ZTS
Founded
1982
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.4B
54.8B
IPO Year
2006
2012

Fundamental Metrics

Financial Performance
Metric
EA
ZTS
Price
$199.66
$127.34
Analyst Decision
Buy
Buy
Analyst Count
20
11
Target Price
$188.20
$156.20
AVG Volume (30 Days)
2.9M
4.3M
Earning Date
05-04-2026
05-14-2026
Dividend Yield
0.38%
1.64%
EPS Growth
N/A
10.05
EPS
1.68
6.02
Revenue
$7,463,000,000.00
$9,467,000,000.00
Revenue This Year
$11.35
$5.79
Revenue Next Year
$3.63
$5.16
P/E Ratio
$119.08
$21.42
Revenue Growth
N/A
2.28
52 Week Low
$128.87
$115.25
52 Week High
$204.89
$177.00

Technical Indicators

Market Signals
Indicator
EA
ZTS
Relative Strength Index (RSI) 39.75 53.52
Support Level $199.12 $124.50
Resistance Level $203.35 $132.49
Average True Range (ATR) 2.02 4.08
MACD -0.16 0.20
Stochastic Oscillator 40.90 61.84

Price Performance

Historical Comparison
EA
ZTS

About EA Electronic Arts Inc.

Electronic Arts is one of the largest global developers and publishers of video games. Its most important franchises are the Madden NFL and FC soccer games, which it releases annually. In 2024, it also relaunched its American college football game. Other major franchises include Apex Legends, Battlefield, and The Sims. Typically, about three quarters of the firm's sales are from in-game spending, with the remainder coming from initial game sales.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: